Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the κ-opioid receptor

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 977-984

  Hjorth, Siv A ^a   Thirstrup, Kenneth ^a   Schwartz, Thue W ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIPRENORPHINE; DYNORPHIN[1-8]; ENADOLINE; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; RADIOLIGAND;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DRUG COMPETITION; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; BENZOFURANS; COS CELLS; DIPRENORPHINE; DYNORPHINS; KINETICS; MUTATION; NARCOTIC ANTAGONISTS; PEPTIDE FRAGMENTS; PYRROLIDINES; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; TRITIUM;

EID: 0029959123     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Yasuda, K., K. Raynor, H. Kong, C. D. Breder, J. Takeda, T. Reisine, and G. I. Bell. Cloning and functional comparison of κ- and δ-opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90:6736-6740 (1993).
2. Kieffer, B. L., K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-12052 (1992).
3. Wang, J. B., Y. Imai, C. P. Eppler, P. Gregor, C. E. Spivak, and G. R. Uhl. μ-Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90:10230-10234 (1993).
4. Reisine, T., and G. I. Bell. Molecular biology of opioid receptors. Trends Neurosci. 16:506-510 (1993).
5. Archer, S. Opioids, in Handbook of Experimental Therapeutics (A. Herz, ed.). Vol. 104/I. Springer-Verlag, NY, 241-277 (1993).
6. Portoghese, P. S., C.-E. Lin, F. Farouz-Grant, and A. E. Takemori. Structure-activity relationship of N17′-substituted norbinaltorphimine congeners: role of the N17′ basic group in the interaction with aputative address subsite on the κ-opioid receptor. J. Med. Chem. 37:1495-1500 (1994).
7. Takemori, A. E., B. Y. Ho, J. S. Naeseth, and P. S. Portoghese. Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 24:255-258 (1988).
8. 3H)U-69593: a highly selective ligand for the opioid κ receptor. Eur. J. Pharmacol. 109:281-284 (1985).
9. Hunter, J. C., G. E. Leighton, K. G. Meecham, S. J. Boyle, D. C. Horwell, D. C. Rees, and J. Hughes. CI-977, a novel and selective agonist for the κ-opioid receptor. Br. J. Pharmacol. 101:183-189 (1990).
10. 3H]-CI-977: a highly selective ligand for the κ-opioid receptor in both guinea-pig and rat forebrain. Mol. Neuropharm. 1:23-29 (1990).
11. Surratt, C. K., P. S. Johnson, A. Moriwaki, B. K. Seidleck, C. J. Blaschak, J. B. Wang, and G. R. UhI. μ-Opiate receptor. J. Biol. Chem. 269:20548-20553 (1994).
12. Wang, J. B., P. S. Johnson, J. M. Wu, W. F. Wang, and G. R. UhI. Human K opiate receptor second extracellular loop elevates dynorphins affinity for human μ/κ chimeras. J. Biol. Chem. 269:25966-25969 (1994).
13. Kong, H., K. Raynor, H. Yano, J. Takeda, G. I. Bell, and T. Reisine. Agonists and antagonists bind to different domains of the cloned κ-opioid receptor. Proc. Natl. Acad. Sci. USA 91:8042-8046 (1994).
14. Xue, J.-C., C. Chen, J. Zhu, S. Kunapuli, J. K. DeRiel, L. Yu, and L.-Y. Liu-Chen. Differential binding domains of peptide and non-peptide ligands in the cloned rat κ opioid receptor. J. Biol. Chem. 269:30195-30199 (1994).
15. Hjorth, S. A., K. Thirstrup, D. K. Grandy, and T. W. Schwartz. Analysis of selective binding epitopes for the κ-opioid receptor antagonist norbinaltorphimine. Mol. Pharmacol. 47:1089-1094 (1995).
16. Xue, J.-C., C. Chen, J. Zhu, S. P. Kunapuli, K. Riel, L. Yu, and L.-Y. Liu-Chen. The third extracellular loop of the μ opioid receptor is important for agonist selectivity. J. Biol. Chem. 270:12977-12979 (1995).
17. Fukuda, K., S. Kato, and K. Mori. Location of regions of the opioid receptor involved in selective agonist binding. J. Biol. Chem. 270:6702-6709 (1995).
18. Meng, F., M. T. Hoversten, R. C. Thompson, L. Taylor, S. J. Watson, and H. Akil. A chimeric study of the molecular basis of affinity and selectivity of the K and the μ opioid receptors. J. Biol. Chem. 270:12730-12736 (1995).
19. Onogi, T., M. Minami, Y. Katao, T. Nakagawa, Y. Aoki, T. Toya, S. Katsumata, and M. Satoh. DAMGO, a μ-opioid receptor selective agonist, distinguishes between μ- and δ-opioid receptors around their first extracellular loops. FEBS Lett. 357:93-97 (1995).
20. Schwartz, T. W., U. Gether, H. T. Shambye, and S. A. Hjorth. Molecular mechanism of action of non-peptide ligands for peptide receptors. Curr. Pharm. Design 1:325-342 (1995).
21. Gether, U., T. E. Johansen, R. M. Snider, J. A. Lowe III, S. Nakanishi, and T. W. Schwartz. Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist. Nature (Lond.) 362:345-348 (1993).
22. Gether, U, L. Nilsson, J. A. Lowe III, and T. W. Schwartz. Specific residues at the top pf transmembrane segments V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP96,345. J. Biol. Chem. 269:23959-23964 (1994).
23. Hjorth, S. A., H. T. Schambye, W. J. Greenlee, and T. W. Schwartz. Identification of peptide binding residues in the extracellular domains of the ATI receptor. J. Biol. Chem. 269:30953-30959 (1994).
24. Schambye, H. T., S. A. Hjorth, D. J. Bergsma, G. Sathe, and T. W. Schwartz. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin type 1 receptors. Proc. Natl. Acad. Sci. USA 91:7046-7050 (1994).
25. Rosenkilde, M. M., M. Cahir, U. Gether, S. A. Hjorth, and T. W. Schwartz. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J. Biol. Chem. 269:28160-28164 (1994).
26. Huang R. C., H. Yu, C. D. Strader, and T. M. Fong. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor. Biochemistry 33:3007-3013 (1994).
27. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (Amst.) 77:51-59 (1989).
28. Gether, U., T. E. Johansen, and T. W. Schwartz. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. J. Biol. Chem. 268:7893-7898 (1993).
29. Lefkowitz, R. J., S. Cotecchia, P. Samama, and T. Costa. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:303-307 (1993).
30. Samama, P., S. Cotecchia, T. Costa, and R. J. Lefkowitz. A mutation-induced activated state of the β2-adrenergic receptor. J. Biol. Chem. 268: 4625-4636 (1993).
31. Kenakin, T. Agonist-receptor efficacy. I. Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16:188-192 (1995).
32. 3H]FK888. Mol. Pharmacol. 44:539-544 (1993).
33. Boyd, N. D., S. G. Macdonald, R. Kage, J. Luber-Narod, and S. E. Leeman. Substance P receptor-biochemical characterization and interactions with G proteins. Ann. N. Y. Acad. Sci. 632:79-93 (1991).
34. Burgisser, E., A. De Lean, and R. J. Lefkowitz. Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotides. Proc. Natl. Acad. Sci. USA 79:1732-1736 (1982).
35. De Lean, A., B. F. Kilpatrick, and M. G. Caron. Dopamine receptor of the porcine anterior pituitary gland: evidence for two affinity states discriminated by both agonists and antagonists. Mol. Pharmacol. 22:290-297 (1982).
36. Chidiac, P., T. E. Hebert, M. Valiquette, M. Dennis, and M. Bouvier. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45: 490-499 (1993).
37. 2-adrenergic receptor. Mol. Pharmacol. 45:390-394 (1994).
38. Pfeiffer, A., W. Sadée, and A. Herz. Differential regulation of the μ-, δ-, and κ-opiate receptor subtypes by guanyl nucleotides and metal ions. J. Neurosci. 2:912-917 (1982).
39. Richardson, A., C. Demoliou-Mason, and E. A. Barnard. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. Proc. Natl. Acad. Sci. USA 89:10198-10202 (1992).